Postdoctoral Associate
Rebecca completed her PhD in Andrew Xiao's lab at Yale, where she studied epigenetic mechanisms of drug resistance in cancer. She is interested in elucidating mechanisms that regulate oncogene amplification and promote tumor evolution.